jueves, 28 de agosto de 2014

NCTR Publications > NCTR Research Highlights

NCTR Publications > NCTR Research Highlights

National Center for Toxicological Researh log with FDA on left side

Current Highlight from August 22, 2014

Bovine Intestinal Bacteria Degrade and Inactivate Ceftiofur
NCTR scientists have shown that ceftiofur—a cephalosporin antimicrobial drug that is approved for veterinary use to treat respiratory disease in cattle, swine, horses, and sheep—is rapidly degraded by bovine intestinal bacteria using a metallo-b-lactamase.  Ceftiofur is structurally similar to the human-use cephalosporin ceftriaxone, and concerns have been raised that use of ceftiofur may adversely impact the effectiveness of other related cephalosporins through the development of antimicrobial resistance.  These results show that bacteria present in the naïve bovine gut are capable of degrading and enzymatically inactivating cephalosporin antimicrobials and reducing environmental exposure to these antimicrobials.  This study is available online atVeterinary Microbiologydisclaimer icon.
For additional information, please contact Bruce Erickson, Ph.D., Staff Fellow, Division of Microbiology, FDA/NCTR.

Contact FDA

National Center for Toxicological Research
Food and Drug Administration
3900 NCTR Road
Jefferson, AR 72079

No hay comentarios:

Publicar un comentario